| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin Class Switching | 78 | 2024 | 289 | 12.430 |
Why?
|
| Immunoglobulin Heavy Chains | 116 | 2024 | 647 | 11.860 |
Why?
|
| B-Lymphocytes | 208 | 2025 | 4787 | 8.670 |
Why?
|
| Recombination, Genetic | 118 | 2024 | 1524 | 7.540 |
Why?
|
| Cytidine Deaminase | 39 | 2023 | 249 | 5.730 |
Why?
|
| DNA Breaks, Double-Stranded | 38 | 2022 | 605 | 5.590 |
Why?
|
| Immunoglobulin Variable Region | 66 | 2024 | 419 | 5.380 |
Why?
|
| Genes, Immunoglobulin | 66 | 2014 | 283 | 5.230 |
Why?
|
| DNA Repair | 70 | 2018 | 2050 | 4.730 |
Why?
|
| DNA-Binding Proteins | 136 | 2022 | 9612 | 4.520 |
Why?
|
| Translocation, Genetic | 40 | 2018 | 1391 | 4.440 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 21 | 2023 | 103 | 3.710 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 24 | 2014 | 110 | 3.020 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 23 | 2013 | 89 | 2.740 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 15 | 2023 | 792 | 2.670 |
Why?
|
| Mice | 426 | 2025 | 81912 | 2.540 |
Why?
|
| Homeodomain Proteins | 33 | 2024 | 2429 | 2.410 |
Why?
|
| HIV Antibodies | 18 | 2025 | 1340 | 2.410 |
Why?
|
| Receptors, Antigen, B-Cell | 19 | 2022 | 546 | 2.400 |
Why?
|
| Antigens, Nuclear | 18 | 2010 | 182 | 2.400 |
Why?
|
| Immunoglobulin Switch Region | 19 | 2017 | 44 | 2.310 |
Why?
|
| VDJ Recombinases | 30 | 2011 | 84 | 2.300 |
Why?
|
| Genomic Instability | 24 | 2020 | 716 | 2.240 |
Why?
|
| Transcription, Genetic | 72 | 2021 | 7611 | 2.100 |
Why?
|
| Animals | 487 | 2025 | 168965 | 2.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 24 | 2019 | 812 | 2.010 |
Why?
|
| Genes, myc | 21 | 2016 | 391 | 1.970 |
Why?
|
| AIDS Vaccines | 15 | 2025 | 900 | 1.940 |
Why?
|
| T-Lymphocytes | 86 | 2019 | 10254 | 1.930 |
Why?
|
| Lymphocytes | 41 | 2013 | 2605 | 1.880 |
Why?
|
| DNA Ligases | 14 | 2010 | 81 | 1.840 |
Why?
|
| Antibodies, Neutralizing | 17 | 2025 | 2011 | 1.830 |
Why?
|
| DNA-Activated Protein Kinase | 17 | 2018 | 111 | 1.790 |
Why?
|
| Precursor Cells, B-Lymphoid | 12 | 2023 | 99 | 1.750 |
Why?
|
| DNA Damage | 34 | 2018 | 2469 | 1.740 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 11 | 2020 | 58 | 1.670 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 12 | 2016 | 354 | 1.660 |
Why?
|
| Nuclear Proteins | 49 | 2021 | 5794 | 1.650 |
Why?
|
| Enhancer Elements, Genetic | 33 | 2021 | 1366 | 1.640 |
Why?
|
| Endonucleases | 11 | 2021 | 371 | 1.630 |
Why?
|
| Lymphoma, B-Cell | 15 | 2015 | 945 | 1.630 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 14 | 2008 | 94 | 1.630 |
Why?
|
| Chromatin | 21 | 2024 | 2980 | 1.610 |
Why?
|
| Antibody Affinity | 4 | 2024 | 251 | 1.550 |
Why?
|
| Sirtuins | 17 | 2013 | 322 | 1.510 |
Why?
|
| Cell Cycle Proteins | 30 | 2020 | 3440 | 1.460 |
Why?
|
| VDJ Exons | 6 | 2015 | 11 | 1.430 |
Why?
|
| DNA Helicases | 16 | 2004 | 854 | 1.390 |
Why?
|
| Immunoglobulin mu-Chains | 18 | 2011 | 62 | 1.390 |
Why?
|
| Proto-Oncogene Proteins c-myc | 27 | 2018 | 998 | 1.370 |
Why?
|
| HIV-1 | 18 | 2025 | 6951 | 1.350 |
Why?
|
| Tumor Suppressor Protein p53 | 28 | 2018 | 2952 | 1.350 |
Why?
|
| Immunoglobulin kappa-Chains | 23 | 2024 | 171 | 1.330 |
Why?
|
| Tumor Suppressor Proteins | 21 | 2017 | 2800 | 1.280 |
Why?
|
| Base Sequence | 113 | 2013 | 12414 | 1.270 |
Why?
|
| Neural Stem Cells | 6 | 2020 | 895 | 1.270 |
Why?
|
| Chromosomes, Mammalian | 7 | 2015 | 148 | 1.250 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 15 | 2009 | 111 | 1.250 |
Why?
|
| Immunoglobulin Light Chains | 20 | 2021 | 289 | 1.240 |
Why?
|
| Allergy and Immunology | 3 | 2019 | 170 | 1.220 |
Why?
|
| Mice, Knockout | 97 | 2024 | 14476 | 1.200 |
Why?
|
| DNA Nucleotidyltransferases | 22 | 2003 | 177 | 1.180 |
Why?
|
| Histones | 23 | 2014 | 2597 | 1.170 |
Why?
|
| Genes, RAG-1 | 12 | 2018 | 68 | 1.150 |
Why?
|
| Cell Line | 88 | 2021 | 15567 | 1.110 |
Why?
|
| Genome | 15 | 2021 | 1752 | 1.100 |
Why?
|
| DNA | 55 | 2023 | 7210 | 1.060 |
Why?
|
| Immunoglobulin Constant Regions | 10 | 2015 | 58 | 1.050 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 7 | 2024 | 381 | 1.040 |
Why?
|
| Antibodies | 12 | 2023 | 2419 | 1.030 |
Why?
|
| Immunoglobulins | 19 | 2021 | 853 | 1.010 |
Why?
|
| Cell Differentiation | 68 | 2020 | 11657 | 1.010 |
Why?
|
| Antibody Diversity | 17 | 2021 | 72 | 0.980 |
Why?
|
| Immunoglobulin Joining Region | 13 | 2024 | 37 | 0.970 |
Why?
|
| Gene Expression Regulation | 67 | 2021 | 11923 | 0.960 |
Why?
|
| Gene Amplification | 16 | 2018 | 1088 | 0.960 |
Why?
|
| Germinal Center | 7 | 2024 | 379 | 0.950 |
Why?
|
| Receptors, Antigen, T-Cell | 31 | 2018 | 2568 | 0.940 |
Why?
|
| Gene Rearrangement | 31 | 2022 | 1141 | 0.930 |
Why?
|
| Cells, Cultured | 69 | 2021 | 18989 | 0.910 |
Why?
|
| Sequence Deletion | 17 | 2019 | 1494 | 0.910 |
Why?
|
| Molecular Sequence Data | 90 | 2015 | 17608 | 0.890 |
Why?
|
| Chromosome Breakage | 7 | 2013 | 159 | 0.890 |
Why?
|
| Mice, Transgenic | 60 | 2021 | 9551 | 0.860 |
Why?
|
| Genes, p53 | 5 | 2020 | 711 | 0.860 |
Why?
|
| Lymphoma | 20 | 2015 | 1896 | 0.850 |
Why?
|
| Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 5 | 2016 | 15 | 0.850 |
Why?
|
| Oncogenes | 15 | 2009 | 1232 | 0.790 |
Why?
|
| Mice, Mutant Strains | 36 | 2019 | 1751 | 0.790 |
Why?
|
| Models, Immunological | 7 | 2015 | 516 | 0.770 |
Why?
|
| Embryonic Stem Cells | 14 | 2020 | 1244 | 0.770 |
Why?
|
| Immunoglobulin M | 15 | 2016 | 1527 | 0.750 |
Why?
|
| Proteins | 34 | 2021 | 6001 | 0.750 |
Why?
|
| Chromosomal Proteins, Non-Histone | 7 | 2020 | 724 | 0.750 |
Why?
|
| Genes, T-Cell Receptor beta | 4 | 2008 | 70 | 0.750 |
Why?
|
| Cell Transformation, Viral | 15 | 2015 | 527 | 0.740 |
Why?
|
| Embryo, Mammalian | 21 | 2013 | 1676 | 0.730 |
Why?
|
| Proto-Oncogenes | 15 | 2006 | 321 | 0.710 |
Why?
|
| DNA, Intergenic | 4 | 2018 | 108 | 0.710 |
Why?
|
| Chimera | 25 | 2020 | 454 | 0.710 |
Why?
|
| Blotting, Southern | 20 | 2015 | 775 | 0.710 |
Why?
|
| Peyer's Patches | 3 | 2020 | 120 | 0.700 |
Why?
|
| Blastocyst | 10 | 2020 | 432 | 0.700 |
Why?
|
| Mammals | 6 | 2018 | 1135 | 0.700 |
Why?
|
| Mutation | 54 | 2025 | 30211 | 0.700 |
Why?
|
| Thymus Neoplasms | 7 | 2010 | 272 | 0.690 |
Why?
|
| Mutagenesis | 11 | 2018 | 1227 | 0.680 |
Why?
|
| Proto-Oncogene Proteins | 30 | 2006 | 4522 | 0.680 |
Why?
|
| HIV Seropositivity | 2 | 2022 | 963 | 0.670 |
Why?
|
| Gene Targeting | 19 | 2016 | 841 | 0.670 |
Why?
|
| RNA, Antisense | 3 | 2016 | 136 | 0.670 |
Why?
|
| Flow Cytometry | 38 | 2016 | 5891 | 0.650 |
Why?
|
| Alleles | 42 | 2024 | 6893 | 0.640 |
Why?
|
| Lymphocyte Activation | 32 | 2021 | 5499 | 0.630 |
Why?
|
| Chromosomes | 8 | 2016 | 578 | 0.620 |
Why?
|
| Nucleic Acid Conformation | 3 | 2021 | 899 | 0.620 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 6 | 2007 | 18 | 0.610 |
Why?
|
| Organogenesis | 2 | 2020 | 214 | 0.600 |
Why?
|
| Mice, Inbred C57BL | 58 | 2021 | 22361 | 0.590 |
Why?
|
| Hybridomas | 21 | 2010 | 442 | 0.580 |
Why?
|
| Multigene Family | 13 | 2020 | 1081 | 0.580 |
Why?
|
| Severe Combined Immunodeficiency | 9 | 2013 | 235 | 0.560 |
Why?
|
| DNA Primers | 18 | 2014 | 2827 | 0.560 |
Why?
|
| Gene Deletion | 19 | 2018 | 2668 | 0.560 |
Why?
|
| Immunoglobulin E | 6 | 2011 | 1496 | 0.550 |
Why?
|
| Immunoglobulin epsilon-Chains | 4 | 2011 | 16 | 0.540 |
Why?
|
| Prosencephalon | 1 | 2018 | 305 | 0.540 |
Why?
|
| Genes | 21 | 1988 | 1824 | 0.520 |
Why?
|
| Actins | 9 | 2012 | 2059 | 0.520 |
Why?
|
| Genetic Techniques | 2 | 2016 | 427 | 0.510 |
Why?
|
| Receptors, Antigen | 6 | 2012 | 51 | 0.510 |
Why?
|
| Immunoglobulin Isotypes | 9 | 2022 | 158 | 0.500 |
Why?
|
| Neurogenesis | 2 | 2020 | 863 | 0.500 |
Why?
|
| Cell Lineage | 12 | 2016 | 2575 | 0.500 |
Why?
|
| B-Lymphocyte Subsets | 7 | 2021 | 240 | 0.490 |
Why?
|
| DNA Breaks | 3 | 2021 | 47 | 0.490 |
Why?
|
| Immunization | 6 | 2016 | 1218 | 0.490 |
Why?
|
| Repressor Proteins | 10 | 2016 | 2979 | 0.480 |
Why?
|
| Immunologic Deficiency Syndromes | 11 | 2010 | 549 | 0.480 |
Why?
|
| DNA Repair Enzymes | 4 | 2016 | 342 | 0.480 |
Why?
|
| DNA Nucleotidylexotransferase | 5 | 2022 | 64 | 0.470 |
Why?
|
| Thymus Gland | 20 | 2011 | 1264 | 0.470 |
Why?
|
| Cloning, Molecular | 28 | 2004 | 4167 | 0.470 |
Why?
|
| Genes, T-Cell Receptor delta | 3 | 2009 | 10 | 0.470 |
Why?
|
| Deoxyribonuclease I | 7 | 2013 | 228 | 0.470 |
Why?
|
| Introns | 12 | 2009 | 965 | 0.460 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2017 | 696 | 0.460 |
Why?
|
| Fibroblasts | 30 | 2018 | 4167 | 0.460 |
Why?
|
| Vaccines | 1 | 2022 | 842 | 0.450 |
Why?
|
| Stem Cells | 27 | 2006 | 3535 | 0.450 |
Why?
|
| Genes, T-Cell Receptor alpha | 3 | 2009 | 19 | 0.450 |
Why?
|
| Viral Matrix Proteins | 1 | 2015 | 193 | 0.450 |
Why?
|
| Serine | 6 | 2013 | 828 | 0.440 |
Why?
|
| Spleen | 23 | 2017 | 2292 | 0.440 |
Why?
|
| Amino Acid Sequence | 41 | 2015 | 13411 | 0.440 |
Why?
|
| Deamination | 6 | 2015 | 25 | 0.440 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2024 | 3667 | 0.430 |
Why?
|
| Genes, Lethal | 7 | 2006 | 224 | 0.430 |
Why?
|
| HIV Infections | 14 | 2025 | 17542 | 0.420 |
Why?
|
| Transcription Factors | 31 | 2016 | 12158 | 0.420 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 4 | 2014 | 167 | 0.420 |
Why?
|
| Cell Transformation, Neoplastic | 18 | 2008 | 2843 | 0.420 |
Why?
|
| Genetic Complementation Test | 13 | 2018 | 556 | 0.420 |
Why?
|
| Radiation Tolerance | 8 | 2013 | 476 | 0.410 |
Why?
|
| Abelson murine leukemia virus | 19 | 1993 | 41 | 0.410 |
Why?
|
| Immunoglobulin G | 14 | 2018 | 4560 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 13 | 2012 | 5796 | 0.400 |
Why?
|
| CHO Cells | 14 | 2003 | 1376 | 0.400 |
Why?
|
| Receptors, Interleukin-2 | 5 | 1999 | 564 | 0.390 |
Why?
|
| Polymerase Chain Reaction | 23 | 2016 | 6067 | 0.390 |
Why?
|
| Complementarity Determining Regions | 5 | 2024 | 154 | 0.390 |
Why?
|
| Restriction Mapping | 18 | 2009 | 848 | 0.390 |
Why?
|
| In Situ Hybridization, Fluorescence | 12 | 2013 | 2509 | 0.380 |
Why?
|
| Chromosome Aberrations | 12 | 2009 | 1776 | 0.380 |
Why?
|
| Immunoglobulin J-Chains | 8 | 1997 | 26 | 0.370 |
Why?
|
| 5' Flanking Region | 1 | 2010 | 31 | 0.370 |
Why?
|
| Cell Cycle | 17 | 2006 | 2927 | 0.360 |
Why?
|
| Humans | 199 | 2025 | 767040 | 0.360 |
Why?
|
| Interleukin-4 | 15 | 2004 | 1156 | 0.360 |
Why?
|
| Apoptosis | 28 | 2021 | 9513 | 0.360 |
Why?
|
| Exoribonucleases | 1 | 2011 | 88 | 0.360 |
Why?
|
| Genes, bcl-2 | 2 | 2004 | 119 | 0.360 |
Why?
|
| Immunoglobulin lambda-Chains | 8 | 2009 | 84 | 0.350 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 10 | 2012 | 163 | 0.350 |
Why?
|
| Radiation, Ionizing | 11 | 2016 | 252 | 0.350 |
Why?
|
| Lymphoid Tissue | 7 | 1999 | 445 | 0.350 |
Why?
|
| Cell Line, Transformed | 14 | 2010 | 861 | 0.350 |
Why?
|
| Growth | 2 | 2010 | 366 | 0.350 |
Why?
|
| Ataxia Telangiectasia | 5 | 2015 | 107 | 0.350 |
Why?
|
| Lipopolysaccharides | 16 | 2012 | 2217 | 0.340 |
Why?
|
| Protein-Tyrosine Kinases | 12 | 2017 | 2428 | 0.340 |
Why?
|
| Gene Silencing | 4 | 2017 | 1505 | 0.330 |
Why?
|
| Orthomyxoviridae | 3 | 2024 | 148 | 0.330 |
Why?
|
| Models, Genetic | 17 | 2006 | 3445 | 0.330 |
Why?
|
| Genes, Switch | 5 | 2002 | 48 | 0.330 |
Why?
|
| Hematopoietic Stem Cells | 14 | 2002 | 3408 | 0.330 |
Why?
|
| Embryonic and Fetal Development | 4 | 2001 | 420 | 0.320 |
Why?
|
| Phosphorylation | 18 | 2022 | 8310 | 0.320 |
Why?
|
| RNA Editing | 3 | 2014 | 149 | 0.320 |
Why?
|
| Exons | 10 | 2009 | 2391 | 0.320 |
Why?
|
| Neurons | 10 | 2020 | 9517 | 0.310 |
Why?
|
| ras Proteins | 4 | 1999 | 1054 | 0.310 |
Why?
|
| Biological Evolution | 3 | 2009 | 1075 | 0.310 |
Why?
|
| Transcription Initiation Site | 3 | 2016 | 190 | 0.310 |
Why?
|
| Chromatids | 3 | 2007 | 62 | 0.310 |
Why?
|
| Cricetinae | 16 | 2003 | 2415 | 0.300 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2020 | 1882 | 0.300 |
Why?
|
| DNA, Complementary | 8 | 2004 | 1989 | 0.300 |
Why?
|
| Carrier Proteins | 10 | 2013 | 4925 | 0.300 |
Why?
|
| RNA, Messenger | 36 | 2024 | 12793 | 0.300 |
Why?
|
| 3' Untranslated Regions | 2 | 2009 | 515 | 0.300 |
Why?
|
| Transfection | 23 | 2013 | 5753 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 15 | 2024 | 9245 | 0.290 |
Why?
|
| Locus Control Region | 2 | 2015 | 21 | 0.290 |
Why?
|
| Multienzyme Complexes | 1 | 2011 | 663 | 0.280 |
Why?
|
| Down-Regulation | 8 | 2021 | 2931 | 0.280 |
Why?
|
| Sirtuin 3 | 4 | 2011 | 66 | 0.280 |
Why?
|
| Mice, SCID | 5 | 2002 | 2626 | 0.280 |
Why?
|
| G1 Phase | 5 | 2021 | 403 | 0.280 |
Why?
|
| Mice, Inbred BALB C | 29 | 2024 | 6226 | 0.280 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2008 | 482 | 0.280 |
Why?
|
| Evolution, Molecular | 4 | 2023 | 1893 | 0.280 |
Why?
|
| Hypergammaglobulinemia | 2 | 2005 | 71 | 0.280 |
Why?
|
| RNA | 9 | 2011 | 2715 | 0.270 |
Why?
|
| Germ-Free Life | 2 | 2020 | 187 | 0.270 |
Why?
|
| Bone Marrow Cells | 17 | 2013 | 2412 | 0.270 |
Why?
|
| Immunoglobulin gamma-Chains | 7 | 1998 | 33 | 0.270 |
Why?
|
| Wiskott-Aldrich Syndrome | 5 | 2003 | 131 | 0.270 |
Why?
|
| Neoplasms | 14 | 2014 | 22350 | 0.270 |
Why?
|
| History, 20th Century | 5 | 2019 | 2765 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 12 | 2013 | 3610 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2015 | 8628 | 0.260 |
Why?
|
| DNA, Circular | 2 | 2021 | 97 | 0.260 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 5 | 2012 | 88 | 0.260 |
Why?
|
| Homozygote | 14 | 2009 | 1774 | 0.250 |
Why?
|
| Hematopoiesis | 12 | 2012 | 2056 | 0.250 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 808 | 0.250 |
Why?
|
| Selection, Genetic | 2 | 2020 | 877 | 0.240 |
Why?
|
| Chromosome Pairing | 2 | 2019 | 46 | 0.240 |
Why?
|
| Epitopes | 5 | 2024 | 2526 | 0.240 |
Why?
|
| T-Lymphocyte Subsets | 7 | 2009 | 1814 | 0.240 |
Why?
|
| Transgenes | 9 | 2014 | 1014 | 0.240 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2004 | 29 | 0.230 |
Why?
|
| Acetylation | 11 | 2011 | 1055 | 0.230 |
Why?
|
| Central Nervous System | 4 | 2000 | 1345 | 0.230 |
Why?
|
| Trihexosylceramides | 1 | 2024 | 29 | 0.230 |
Why?
|
| Cytosine Deaminase | 1 | 2004 | 63 | 0.230 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2004 | 31 | 0.230 |
Why?
|
| Cell Division | 13 | 2004 | 4473 | 0.230 |
Why?
|
| Ferritins | 2 | 2024 | 601 | 0.230 |
Why?
|
| Cell Movement | 6 | 2012 | 5203 | 0.230 |
Why?
|
| Phenotype | 22 | 2020 | 16718 | 0.220 |
Why?
|
| cdc42 GTP-Binding Protein | 3 | 2002 | 187 | 0.220 |
Why?
|
| Suppression, Genetic | 1 | 2004 | 190 | 0.220 |
Why?
|
| Genetic Vectors | 10 | 2015 | 3402 | 0.220 |
Why?
|
| Enzyme Activation | 5 | 2009 | 3587 | 0.220 |
Why?
|
| Interleukin-7 | 3 | 1994 | 146 | 0.220 |
Why?
|
| Chromosome Mapping | 16 | 2021 | 4616 | 0.220 |
Why?
|
| Neoplasms, Experimental | 3 | 2008 | 1228 | 0.220 |
Why?
|
| Nanoparticles | 3 | 2024 | 1966 | 0.210 |
Why?
|
| Signal Transduction | 32 | 2022 | 23621 | 0.210 |
Why?
|
| Replication Protein A | 4 | 2008 | 54 | 0.210 |
Why?
|
| Cytidine | 1 | 2003 | 60 | 0.210 |
Why?
|
| Sequence Homology, Nucleic Acid | 10 | 2005 | 1057 | 0.210 |
Why?
|
| Leukemia Virus, Murine | 6 | 1995 | 95 | 0.210 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2024 | 255 | 0.210 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2024 | 426 | 0.210 |
Why?
|
| Longevity | 4 | 2009 | 1083 | 0.210 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 18330 | 0.210 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2003 | 163 | 0.210 |
Why?
|
| Cell Surface Extensions | 2 | 2003 | 65 | 0.200 |
Why?
|
| Antibodies, Viral | 3 | 2024 | 3212 | 0.200 |
Why?
|
| Recombinant Fusion Proteins | 9 | 2010 | 3738 | 0.200 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2024 | 306 | 0.200 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 3043 | 0.200 |
Why?
|
| Neomycin | 2 | 1999 | 94 | 0.200 |
Why?
|
| Epigenesis, Genetic | 4 | 2012 | 3828 | 0.200 |
Why?
|
| DNA Fragmentation | 2 | 2021 | 238 | 0.200 |
Why?
|
| Gene Expression | 23 | 2021 | 7587 | 0.200 |
Why?
|
| Ultraviolet Rays | 2 | 2004 | 1101 | 0.190 |
Why?
|
| Histone Deacetylases | 4 | 2008 | 712 | 0.190 |
Why?
|
| Antibody Formation | 9 | 2024 | 1392 | 0.190 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2014 | 1836 | 0.190 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2000 | 32 | 0.190 |
Why?
|
| Fetal Death | 4 | 2004 | 434 | 0.190 |
Why?
|
| DNA Replication | 2 | 2020 | 1426 | 0.190 |
Why?
|
| Avian Proteins | 1 | 2021 | 77 | 0.190 |
Why?
|
| Germ Cells | 2 | 2018 | 644 | 0.190 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2009 | 566 | 0.190 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2003 | 1244 | 0.190 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2021 | 108 | 0.190 |
Why?
|
| Point Mutation | 4 | 2011 | 1591 | 0.180 |
Why?
|
| Sirtuin 1 | 9 | 2008 | 247 | 0.180 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2021 | 62 | 0.180 |
Why?
|
| Blotting, Northern | 11 | 2000 | 1550 | 0.180 |
Why?
|
| Models, Biological | 15 | 2011 | 9464 | 0.180 |
Why?
|
| Tandem Repeat Sequences | 2 | 2022 | 183 | 0.180 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2006 | 606 | 0.180 |
Why?
|
| Zebrafish | 3 | 2009 | 3036 | 0.180 |
Why?
|
| Membrane Fusion | 1 | 2022 | 265 | 0.180 |
Why?
|
| Reactive Oxygen Species | 2 | 2008 | 2144 | 0.180 |
Why?
|
| Heterozygote | 11 | 2016 | 2794 | 0.180 |
Why?
|
| Medulloblastoma | 1 | 2006 | 682 | 0.180 |
Why?
|
| Immune System | 4 | 2008 | 799 | 0.180 |
Why?
|
| Mutation, Missense | 4 | 2011 | 2592 | 0.180 |
Why?
|
| beta-Lactamases | 1 | 2002 | 307 | 0.180 |
Why?
|
| Indoleacetic Acids | 1 | 2020 | 44 | 0.180 |
Why?
|
| Cytoskeleton | 6 | 2010 | 1178 | 0.180 |
Why?
|
| Aging | 11 | 2009 | 8729 | 0.170 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2000 | 122 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2015 | 286 | 0.170 |
Why?
|
| Macaca mulatta | 2 | 2024 | 2345 | 0.170 |
Why?
|
| DNA, Single-Stranded | 4 | 2023 | 351 | 0.170 |
Why?
|
| Vaccination | 6 | 2024 | 3434 | 0.170 |
Why?
|
| Caloric Restriction | 4 | 2010 | 302 | 0.160 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2009 | 2745 | 0.160 |
Why?
|
| Substrate Specificity | 5 | 2017 | 1750 | 0.160 |
Why?
|
| Burkitt Lymphoma | 1 | 2021 | 338 | 0.160 |
Why?
|
| Phosphoproteins | 6 | 2006 | 2448 | 0.160 |
Why?
|
| Antigens, CD | 8 | 2002 | 4032 | 0.160 |
Why?
|
| Genes, Regulator | 4 | 2004 | 373 | 0.160 |
Why?
|
| Membrane Glycoproteins | 8 | 2006 | 3702 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2018 | 1074 | 0.160 |
Why?
|
| Conserved Sequence | 3 | 2009 | 1160 | 0.160 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2018 | 428 | 0.160 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 1998 | 147 | 0.160 |
Why?
|
| Genetic Loci | 3 | 2015 | 2629 | 0.150 |
Why?
|
| DNA, Recombinant | 5 | 2005 | 455 | 0.150 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 645 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 1998 | 635 | 0.150 |
Why?
|
| Autoantibodies | 7 | 2010 | 2114 | 0.150 |
Why?
|
| Integrases | 5 | 2012 | 520 | 0.150 |
Why?
|
| Binding Sites, Antibody | 1 | 2018 | 340 | 0.150 |
Why?
|
| Microfilament Proteins | 1 | 2003 | 1130 | 0.150 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2017 | 27 | 0.150 |
Why?
|
| Mitochondria, Liver | 2 | 2009 | 190 | 0.150 |
Why?
|
| Germ-Line Mutation | 3 | 2021 | 1885 | 0.150 |
Why?
|
| Luminescent Proteins | 2 | 2002 | 839 | 0.140 |
Why?
|
| Lymphocyte Subsets | 1 | 1998 | 313 | 0.140 |
Why?
|
| Mice, Inbred CBA | 5 | 1999 | 439 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 4572 | 0.140 |
Why?
|
| Protein Sorting Signals | 1 | 2018 | 274 | 0.140 |
Why?
|
| Vaccinia virus | 3 | 2012 | 328 | 0.140 |
Why?
|
| Peptide Fragments | 2 | 2008 | 5141 | 0.140 |
Why?
|
| Cell Compartmentation | 1 | 1998 | 383 | 0.140 |
Why?
|
| Neuroblastoma | 7 | 1988 | 1266 | 0.140 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 549 | 0.140 |
Why?
|
| Trans-Activators | 5 | 2008 | 2856 | 0.140 |
Why?
|
| Cell Proliferation | 10 | 2020 | 10455 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-vav | 9 | 2003 | 91 | 0.140 |
Why?
|
| Gene Knock-In Techniques | 5 | 2019 | 419 | 0.140 |
Why?
|
| Binding Sites | 9 | 2024 | 6014 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2007 | 2887 | 0.140 |
Why?
|
| Mice, Inbred Strains | 11 | 2011 | 1765 | 0.140 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2016 | 35 | 0.140 |
Why?
|
| Protein Engineering | 2 | 2024 | 554 | 0.140 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2021 | 1677 | 0.140 |
Why?
|
| Sensory Receptor Cells | 1 | 2021 | 509 | 0.130 |
Why?
|
| Leukemia, Experimental | 5 | 1991 | 224 | 0.130 |
Why?
|
| Immunophenotyping | 5 | 2015 | 1864 | 0.130 |
Why?
|
| Lymphoma, T-Cell | 3 | 2015 | 308 | 0.130 |
Why?
|
| Wilms Tumor | 3 | 1988 | 378 | 0.130 |
Why?
|
| Protein Binding | 8 | 2017 | 9327 | 0.130 |
Why?
|
| Lysine | 3 | 2010 | 998 | 0.130 |
Why?
|
| Receptors, IgE | 5 | 2003 | 375 | 0.130 |
Why?
|
| Genes, Homeobox | 2 | 1997 | 289 | 0.130 |
Why?
|
| Genotype | 7 | 2015 | 13035 | 0.130 |
Why?
|
| Sequence Alignment | 5 | 2008 | 2176 | 0.130 |
Why?
|
| Chromosomal Instability | 2 | 2009 | 176 | 0.130 |
Why?
|
| Mutagenesis, Insertional | 3 | 2008 | 661 | 0.130 |
Why?
|
| Homeostasis | 4 | 2020 | 3345 | 0.130 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 464 | 0.130 |
Why?
|
| Clone Cells | 6 | 2010 | 1669 | 0.120 |
Why?
|
| Nerve Tissue Proteins | 4 | 2016 | 4401 | 0.120 |
Why?
|
| Lentivirus | 2 | 2010 | 518 | 0.120 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 353 | 0.120 |
Why?
|
| beta-Globins | 1 | 2015 | 111 | 0.120 |
Why?
|
| Cricetulus | 2 | 1996 | 810 | 0.120 |
Why?
|
| Liver | 17 | 2010 | 7578 | 0.120 |
Why?
|
| Agammaglobulinemia | 4 | 1998 | 173 | 0.120 |
Why?
|
| Organ Specificity | 4 | 2012 | 1966 | 0.120 |
Why?
|
| Neocortex | 1 | 2018 | 414 | 0.120 |
Why?
|
| Lectins | 1 | 1997 | 490 | 0.120 |
Why?
|
| Immunologic Surveillance | 1 | 2015 | 92 | 0.120 |
Why?
|
| YY1 Transcription Factor | 2 | 2013 | 60 | 0.120 |
Why?
|
| Female | 53 | 2024 | 396660 | 0.120 |
Why?
|
| Frameshift Mutation | 1 | 1996 | 392 | 0.120 |
Why?
|
| Telomere | 4 | 2007 | 943 | 0.120 |
Why?
|
| Genes, jun | 1 | 1994 | 69 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2007 | 4405 | 0.110 |
Why?
|
| Amination | 2 | 2004 | 17 | 0.110 |
Why?
|
| NF-kappa B | 3 | 2015 | 2493 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2012 | 2902 | 0.110 |
Why?
|
| Gene Knockout Techniques | 2 | 2015 | 804 | 0.110 |
Why?
|
| Blotting, Western | 9 | 2013 | 5022 | 0.110 |
Why?
|
| Protein Kinases | 2 | 1998 | 1610 | 0.110 |
Why?
|
| Karyotyping | 6 | 2018 | 1176 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2008 | 1405 | 0.110 |
Why?
|
| Mast Cells | 5 | 2003 | 1405 | 0.110 |
Why?
|
| Mitochondrial Proteins | 2 | 2011 | 980 | 0.110 |
Why?
|
| Lymphopenia | 2 | 2015 | 300 | 0.110 |
Why?
|
| DNA Restriction Enzymes | 9 | 1987 | 548 | 0.110 |
Why?
|
| Interleukins | 2 | 1988 | 796 | 0.110 |
Why?
|
| Brain | 12 | 2020 | 27163 | 0.110 |
Why?
|
| Axons | 1 | 2021 | 1675 | 0.110 |
Why?
|
| Weaning | 1 | 2013 | 102 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2014 | 3804 | 0.110 |
Why?
|
| Feces | 1 | 2020 | 1508 | 0.110 |
Why?
|
| Mitochondria | 4 | 2010 | 3678 | 0.110 |
Why?
|
| Cell Separation | 5 | 2012 | 1717 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2017 | 699 | 0.100 |
Why?
|
| Rad51 Recombinase | 3 | 2005 | 191 | 0.100 |
Why?
|
| Immunity, Innate | 2 | 2021 | 3076 | 0.100 |
Why?
|
| Macromolecular Substances | 4 | 2004 | 1430 | 0.100 |
Why?
|
| Genes, Reporter | 4 | 2017 | 1526 | 0.100 |
Why?
|
| Bone Marrow | 11 | 2000 | 2926 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2018 | 950 | 0.100 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2012 | 26 | 0.100 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 3 | 2011 | 153 | 0.100 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 1889 | 0.100 |
Why?
|
| Antigens, Surface | 6 | 2016 | 1617 | 0.100 |
Why?
|
| Cytogenetic Analysis | 2 | 2010 | 270 | 0.100 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 904 | 0.100 |
Why?
|
| Telomere-Binding Proteins | 1 | 2013 | 122 | 0.100 |
Why?
|
| Plasmids | 4 | 2009 | 2268 | 0.100 |
Why?
|
| Immunoglobulin D | 2 | 1999 | 55 | 0.100 |
Why?
|
| Myosin Light Chains | 1 | 1992 | 121 | 0.100 |
Why?
|
| RNA Interference | 3 | 2018 | 2829 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 178 | 0.100 |
Why?
|
| Male | 41 | 2024 | 364203 | 0.100 |
Why?
|
| Genes, ras | 4 | 2005 | 656 | 0.100 |
Why?
|
| Mesenchymoma | 1 | 1992 | 50 | 0.100 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1992 | 64 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2009 | 1965 | 0.090 |
Why?
|
| Canaries | 1 | 1991 | 6 | 0.090 |
Why?
|
| Immunization, Secondary | 2 | 2024 | 373 | 0.090 |
Why?
|
| Catalysis | 2 | 2018 | 766 | 0.090 |
Why?
|
| Oncogene Proteins | 3 | 2012 | 715 | 0.090 |
Why?
|
| Survival Rate | 8 | 2008 | 12823 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2005 | 705 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 1997 | 3599 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 2010 | 15 | 0.090 |
Why?
|
| Models, Molecular | 2 | 2018 | 5388 | 0.090 |
Why?
|
| BRCA1 Protein | 5 | 2017 | 1155 | 0.090 |
Why?
|
| Infertility, Male | 3 | 2013 | 396 | 0.090 |
Why?
|
| Symbiosis | 1 | 2013 | 297 | 0.090 |
Why?
|
| Shigella flexneri | 2 | 2002 | 118 | 0.090 |
Why?
|
| Nucleotides | 1 | 1993 | 454 | 0.090 |
Why?
|
| DNA Mutational Analysis | 5 | 2011 | 4114 | 0.090 |
Why?
|
| Ketone Bodies | 1 | 2010 | 76 | 0.090 |
Why?
|
| Chickens | 3 | 2021 | 843 | 0.090 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2011 | 99 | 0.090 |
Why?
|
| Myosins | 1 | 1992 | 406 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1592 | 0.090 |
Why?
|
| Cytological Techniques | 1 | 2012 | 217 | 0.090 |
Why?
|
| Antibody Specificity | 3 | 2013 | 1062 | 0.090 |
Why?
|
| NIH 3T3 Cells | 3 | 2008 | 655 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 1997 | 1612 | 0.090 |
Why?
|
| src Homology Domains | 3 | 2000 | 360 | 0.090 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2011 | 200 | 0.090 |
Why?
|
| Antibody-Producing Cells | 1 | 2010 | 140 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2007 | 4648 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2020 | 1239 | 0.090 |
Why?
|
| Glutamate Dehydrogenase | 2 | 2007 | 50 | 0.090 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2010 | 49 | 0.090 |
Why?
|
| NAD | 3 | 2009 | 618 | 0.090 |
Why?
|
| Chromosome Breakpoints | 1 | 2009 | 93 | 0.080 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2009 | 67 | 0.080 |
Why?
|
| Exodeoxyribonucleases | 1 | 2011 | 191 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2006 | 2678 | 0.080 |
Why?
|
| Philadelphia Chromosome | 1 | 2010 | 119 | 0.080 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 334 | 0.080 |
Why?
|
| Mitogens | 4 | 2001 | 229 | 0.080 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2010 | 175 | 0.080 |
Why?
|
| Receptors, Complement 3d | 1 | 2009 | 117 | 0.080 |
Why?
|
| X Chromosome | 3 | 1995 | 819 | 0.080 |
Why?
|
| Phosphoglycerate Kinase | 2 | 1999 | 66 | 0.080 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1994 | 705 | 0.080 |
Why?
|
| Cell Survival | 7 | 2015 | 5750 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 4 | 2006 | 6106 | 0.080 |
Why?
|
| Structure-Activity Relationship | 5 | 2017 | 3052 | 0.080 |
Why?
|
| Feedback, Physiological | 1 | 2011 | 481 | 0.080 |
Why?
|
| Pseudogenes | 2 | 1991 | 104 | 0.080 |
Why?
|
| Interphase | 1 | 2009 | 226 | 0.080 |
Why?
|
| Saccharomycetales | 1 | 2009 | 74 | 0.080 |
Why?
|
| Embryo Loss | 1 | 2008 | 55 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 3 | 2015 | 4780 | 0.080 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2003 | 440 | 0.080 |
Why?
|
| DNA Probes | 2 | 2008 | 541 | 0.080 |
Why?
|
| Metaphase | 2 | 2007 | 143 | 0.080 |
Why?
|
| Obesity | 1 | 2010 | 13085 | 0.080 |
Why?
|
| Fetal Viability | 1 | 2008 | 23 | 0.080 |
Why?
|
| Sister Chromatid Exchange | 2 | 2006 | 60 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 2 | 2005 | 84 | 0.070 |
Why?
|
| Species Specificity | 2 | 2009 | 2412 | 0.070 |
Why?
|
| Cell Death | 4 | 2013 | 1677 | 0.070 |
Why?
|
| Xenopus laevis | 2 | 2004 | 966 | 0.070 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 384 | 0.070 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2007 | 62 | 0.070 |
Why?
|
| Immunoglobulin Fragments | 2 | 2004 | 83 | 0.070 |
Why?
|
| Carbon-Carbon Double Bond Isomerases | 1 | 2007 | 5 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2013 | 1574 | 0.070 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2007 | 11 | 0.070 |
Why?
|
| Fasting | 2 | 2010 | 1607 | 0.070 |
Why?
|
| Acetyl-CoA C-Acyltransferase | 1 | 2007 | 23 | 0.070 |
Why?
|
| Sequence Analysis, Protein | 1 | 2008 | 261 | 0.070 |
Why?
|
| Gene Library | 3 | 2016 | 1065 | 0.070 |
Why?
|
| Chromosome Deletion | 5 | 2001 | 1384 | 0.070 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2007 | 59 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2013 | 811 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2004 | 294 | 0.070 |
Why?
|
| Animals, Newborn | 5 | 2004 | 2677 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 899 | 0.070 |
Why?
|
| Endodeoxyribonucleases | 2 | 2021 | 165 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2008 | 816 | 0.070 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 183 | 0.070 |
Why?
|
| S Phase | 2 | 2005 | 424 | 0.070 |
Why?
|
| Racemases and Epimerases | 1 | 2007 | 113 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 386 | 0.070 |
Why?
|
| Aspartic Acid | 1 | 2008 | 575 | 0.070 |
Why?
|
| Leukemia | 3 | 2011 | 1518 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 8 | 1992 | 1305 | 0.070 |
Why?
|
| 3' Flanking Region | 2 | 2002 | 14 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2007 | 361 | 0.060 |
Why?
|
| Mitochondria, Muscle | 1 | 2007 | 171 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 1991 | 1562 | 0.060 |
Why?
|
| Hippocampus | 1 | 2018 | 3777 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2009 | 4349 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 4 | 2010 | 2063 | 0.060 |
Why?
|
| Deoxyribonucleases | 3 | 2016 | 209 | 0.060 |
Why?
|
| Oxidative Stress | 3 | 2008 | 3139 | 0.060 |
Why?
|
| Cell Nucleus | 5 | 2004 | 2875 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-abl | 2 | 1996 | 145 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2006 | 261 | 0.060 |
Why?
|
| Genomic Library | 3 | 1996 | 189 | 0.060 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 2 | 1997 | 318 | 0.060 |
Why?
|
| Biopolymers | 2 | 2003 | 182 | 0.060 |
Why?
|
| Crosses, Genetic | 3 | 2008 | 751 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2020 | 6597 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 4 | 2009 | 2628 | 0.060 |
Why?
|
| Neutropenia | 1 | 2010 | 892 | 0.060 |
Why?
|
| Receptor Aggregation | 2 | 2003 | 72 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2017 | 2883 | 0.060 |
Why?
|
| Antisense Elements (Genetics) | 1 | 2004 | 37 | 0.060 |
Why?
|
| Colitis | 3 | 2007 | 1238 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2008 | 670 | 0.060 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2005 | 167 | 0.060 |
Why?
|
| Gene Dosage | 2 | 2007 | 1211 | 0.060 |
Why?
|
| Sequence Homology | 1 | 2004 | 197 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2744 | 0.060 |
Why?
|
| Encephalomyocarditis virus | 1 | 2003 | 21 | 0.060 |
Why?
|
| Cardiovirus Infections | 1 | 2003 | 20 | 0.060 |
Why?
|
| Tubulin | 1 | 2008 | 694 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2021 | 4280 | 0.060 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1988 | 594 | 0.060 |
Why?
|
| Immune Tolerance | 2 | 2010 | 2322 | 0.060 |
Why?
|
| Base Composition | 2 | 2003 | 291 | 0.060 |
Why?
|
| Leukemia, B-Cell | 1 | 2004 | 86 | 0.050 |
Why?
|
| Immune System Diseases | 2 | 2002 | 253 | 0.050 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2003 | 35 | 0.050 |
Why?
|
| Protein Isoforms | 3 | 2003 | 1716 | 0.050 |
Why?
|
| Hybrid Cells | 4 | 1995 | 421 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2004 | 247 | 0.050 |
Why?
|
| Extrachromosomal Inheritance | 1 | 2003 | 18 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 3 | 2002 | 661 | 0.050 |
Why?
|
| Mitomycin | 1 | 2004 | 261 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2001 | 317 | 0.050 |
Why?
|
| Recombinant Proteins | 6 | 2004 | 6507 | 0.050 |
Why?
|
| Templates, Genetic | 1 | 2003 | 188 | 0.050 |
Why?
|
| Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 2 | 1995 | 40 | 0.050 |
Why?
|
| TATA Box | 1 | 2003 | 127 | 0.050 |
Why?
|
| Pseudopodia | 1 | 2003 | 167 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 2 | 2015 | 190 | 0.050 |
Why?
|
| Death | 1 | 2007 | 685 | 0.050 |
Why?
|
| RNA, Neoplasm | 4 | 1992 | 748 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2008 | 722 | 0.050 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2017 | 1642 | 0.050 |
Why?
|
| NFATC Transcription Factors | 6 | 2002 | 393 | 0.050 |
Why?
|
| Fertility | 2 | 2004 | 771 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 1424 | 0.050 |
Why?
|
| Receptor, Notch1 | 1 | 2005 | 518 | 0.050 |
Why?
|
| Pre-B Cell Receptors | 1 | 2002 | 3 | 0.050 |
Why?
|
| Immunologic Capping | 2 | 2000 | 30 | 0.050 |
Why?
|
| Cell Line, Tumor | 6 | 2018 | 17097 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1433 | 0.050 |
Why?
|
| Fetus | 6 | 1990 | 1878 | 0.050 |
Why?
|
| Osteosarcoma | 1 | 2008 | 910 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2000 | 610 | 0.050 |
Why?
|
| DNA Methylation | 3 | 2013 | 4426 | 0.050 |
Why?
|
| Kidney Neoplasms | 3 | 1988 | 4282 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2001 | 616 | 0.050 |
Why?
|
| Myelopoiesis | 1 | 2003 | 135 | 0.050 |
Why?
|
| Kidney | 7 | 1999 | 7063 | 0.050 |
Why?
|
| Listeria | 1 | 2001 | 25 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2010 | 1806 | 0.050 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2003 | 93 | 0.050 |
Why?
|
| DNA, Neoplasm | 5 | 1992 | 1741 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 4 | 2016 | 1144 | 0.050 |
Why?
|
| Feedback | 1 | 2006 | 797 | 0.050 |
Why?
|
| Methylation | 2 | 1995 | 1076 | 0.050 |
Why?
|
| Cell Degranulation | 2 | 2003 | 276 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 316 | 0.050 |
Why?
|
| Syndrome | 2 | 2010 | 3271 | 0.050 |
Why?
|
| Retroviridae | 4 | 2002 | 846 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2005 | 740 | 0.050 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 2 | 1998 | 67 | 0.050 |
Why?
|
| Genome, Human | 1 | 2014 | 4441 | 0.050 |
Why?
|
| Sirtuin 2 | 3 | 2007 | 93 | 0.050 |
Why?
|
| Recombinases | 2 | 2012 | 70 | 0.050 |
Why?
|
| Enzyme Induction | 3 | 2004 | 455 | 0.050 |
Why?
|
| Antigens, CD1 | 1 | 2003 | 434 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2020 | 976 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2010 | 1518 | 0.050 |
Why?
|
| Life Expectancy | 3 | 2009 | 1248 | 0.050 |
Why?
|
| Mitosis | 1 | 2006 | 1176 | 0.050 |
Why?
|
| Phylogeny | 1 | 2008 | 2840 | 0.050 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2022 | 446 | 0.050 |
Why?
|
| Mice, 129 Strain | 2 | 2012 | 367 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2004 | 689 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 1995 | 897 | 0.040 |
Why?
|
| Concanavalin A | 1 | 2000 | 189 | 0.040 |
Why?
|
| Th2 Cells | 2 | 2004 | 1077 | 0.040 |
Why?
|
| Diencephalon | 1 | 2000 | 54 | 0.040 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2000 | 111 | 0.040 |
Why?
|
| Peptide Synthases | 1 | 2000 | 81 | 0.040 |
Why?
|
| Integrins | 2 | 2002 | 840 | 0.040 |
Why?
|
| Receptors, OX40 | 1 | 2020 | 46 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2006 | 1350 | 0.040 |
Why?
|
| Time Factors | 6 | 2010 | 40154 | 0.040 |
Why?
|
| Metallurgy | 1 | 2000 | 90 | 0.040 |
Why?
|
| Autophagy | 1 | 2008 | 1347 | 0.040 |
Why?
|
| Body Weight | 1 | 2010 | 4627 | 0.040 |
Why?
|
| Leucine Zippers | 2 | 1997 | 116 | 0.040 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2000 | 57 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 2000 | 240 | 0.040 |
Why?
|
| Interferon-gamma | 3 | 2003 | 3154 | 0.040 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2003 | 892 | 0.040 |
Why?
|
| Myelin Proteins | 2 | 1990 | 212 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2004 | 1040 | 0.040 |
Why?
|
| Cullin Proteins | 1 | 2000 | 180 | 0.040 |
Why?
|
| Platinum Compounds | 1 | 2000 | 94 | 0.040 |
Why?
|
| IgA Deficiency | 1 | 1999 | 39 | 0.040 |
Why?
|
| Pregnancy | 8 | 2008 | 30238 | 0.040 |
Why?
|
| Spermatogenesis | 2 | 2013 | 260 | 0.040 |
Why?
|
| Antibodies, Blocking | 1 | 2020 | 250 | 0.040 |
Why?
|
| Membrane Microdomains | 1 | 2000 | 205 | 0.040 |
Why?
|
| Dimerization | 2 | 1998 | 882 | 0.040 |
Why?
|
| Mass Spectrometry | 3 | 2011 | 2201 | 0.040 |
Why?
|
| Plasmacytoma | 3 | 1992 | 170 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 3 | 1989 | 1079 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2006 | 898 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2000 | 365 | 0.040 |
Why?
|
| Tissue Distribution | 3 | 2000 | 2275 | 0.040 |
Why?
|
| Gamma Rays | 2 | 1997 | 324 | 0.040 |
Why?
|
| Catalytic Domain | 2 | 2017 | 699 | 0.040 |
Why?
|
| Passive Cutaneous Anaphylaxis | 1 | 1998 | 31 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2005 | 2229 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2003 | 703 | 0.040 |
Why?
|
| Genes, BRCA1 | 1 | 2002 | 753 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 1998 | 313 | 0.040 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2018 | 111 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12790 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2011 | 857 | 0.040 |
Why?
|
| Purkinje Cells | 1 | 2000 | 228 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 2 | 1990 | 340 | 0.040 |
Why?
|
| Macaca | 1 | 2019 | 413 | 0.040 |
Why?
|
| RNA, Small Interfering | 3 | 2017 | 3427 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2022 | 994 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2000 | 271 | 0.040 |
Why?
|
| Liposomes | 1 | 2022 | 787 | 0.040 |
Why?
|
| Interleukin-2 | 4 | 2002 | 1894 | 0.040 |
Why?
|
| Thymidine Kinase | 3 | 1989 | 286 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2001 | 599 | 0.040 |
Why?
|
| Globins | 1 | 1998 | 405 | 0.040 |
Why?
|
| Sciatic Nerve | 1 | 2021 | 627 | 0.040 |
Why?
|
| Genetic Engineering | 3 | 1990 | 935 | 0.040 |
Why?
|
| Telomerase | 1 | 2003 | 751 | 0.040 |
Why?
|
| Chromones | 2 | 2013 | 148 | 0.040 |
Why?
|
| Genes, Essential | 1 | 1998 | 185 | 0.040 |
Why?
|
| GPI-Linked Proteins | 2 | 2016 | 472 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 1995 | 1729 | 0.040 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 1997 | 97 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 874 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 9108 | 0.030 |
Why?
|
| Lymphokines | 2 | 1991 | 924 | 0.030 |
Why?
|
| Immunoglobulin Idiotypes | 2 | 1987 | 200 | 0.030 |
Why?
|
| Leukocytes | 1 | 2005 | 2034 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 2010 | 2815 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2008 | 2591 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 492 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2002 | 1195 | 0.030 |
Why?
|
| Aphidicolin | 1 | 2016 | 37 | 0.030 |
Why?
|
| In Situ Hybridization | 3 | 1998 | 1892 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2011 | 3797 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2002 | 1250 | 0.030 |
Why?
|
| Trinitrobenzenes | 2 | 2012 | 45 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2017 | 3948 | 0.030 |
Why?
|
| DNA, Fungal | 1 | 1997 | 275 | 0.030 |
Why?
|
| Receptors, Complement | 1 | 1997 | 254 | 0.030 |
Why?
|
| Immunoglobulin delta-Chains | 2 | 1998 | 7 | 0.030 |
Why?
|
| Autoimmune Diseases | 5 | 2000 | 2255 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 3 | 2010 | 1626 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2010 | 4143 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 2 | 1994 | 321 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2008 | 2563 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 1998 | 539 | 0.030 |
Why?
|
| Zygote | 1 | 1996 | 117 | 0.030 |
Why?
|
| Nerve Regeneration | 1 | 2021 | 796 | 0.030 |
Why?
|
| Gene Expression Profiling | 5 | 2011 | 9532 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1993 | 2168 | 0.030 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 1995 | 66 | 0.030 |
Why?
|
| Platelet Count | 1 | 1998 | 784 | 0.030 |
Why?
|
| Nervous System | 1 | 1999 | 543 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 1999 | 992 | 0.030 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2015 | 38 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2017 | 349 | 0.030 |
Why?
|
| Antigens, T-Independent | 1 | 1994 | 20 | 0.030 |
Why?
|
| Quinazolinones | 1 | 2017 | 219 | 0.030 |
Why?
|
| Dysgammaglobulinemia | 1 | 1994 | 19 | 0.030 |
Why?
|
| Amino Acid Substitution | 2 | 2010 | 1743 | 0.030 |
Why?
|
| Drug Resistance | 3 | 1998 | 1592 | 0.030 |
Why?
|
| X-Rays | 1 | 1996 | 311 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 694 | 0.030 |
Why?
|
| Antigens | 2 | 2016 | 1442 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1996 | 238 | 0.030 |
Why?
|
| Lymph Nodes | 2 | 2013 | 3468 | 0.030 |
Why?
|
| bcl-X Protein | 3 | 2002 | 412 | 0.030 |
Why?
|
| HeLa Cells | 3 | 2006 | 3073 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 203 | 0.030 |
Why?
|
| Body Patterning | 1 | 1998 | 634 | 0.030 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2016 | 262 | 0.030 |
Why?
|
| Morpholines | 2 | 2013 | 584 | 0.030 |
Why?
|
| Receptors, Immunologic | 2 | 1993 | 1418 | 0.030 |
Why?
|
| CD40 Ligand | 2 | 2011 | 528 | 0.030 |
Why?
|
| Enzyme Inhibitors | 3 | 2017 | 3726 | 0.030 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2017 | 238 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1996 | 327 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2003 | 572 | 0.030 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2014 | 125 | 0.030 |
Why?
|
| Kanamycin Kinase | 1 | 1993 | 34 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2018 | 923 | 0.030 |
Why?
|
| Cell Adhesion | 2 | 2016 | 3093 | 0.030 |
Why?
|
| Molecular Biology | 1 | 1997 | 573 | 0.030 |
Why?
|
| Muscle, Skeletal | 3 | 2008 | 4968 | 0.030 |
Why?
|
| Lymphocyte Count | 3 | 2002 | 793 | 0.030 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2013 | 61 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 166 | 0.030 |
Why?
|
| Rats | 5 | 1993 | 23713 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 1997 | 592 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 1997 | 691 | 0.030 |
Why?
|
| Purines | 1 | 2017 | 614 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 733 | 0.030 |
Why?
|
| Eye | 1 | 1997 | 711 | 0.030 |
Why?
|
| Jurkat Cells | 3 | 2000 | 740 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1994 | 287 | 0.030 |
Why?
|
| Immunoblotting | 2 | 2010 | 1647 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2017 | 1688 | 0.030 |
Why?
|
| Cell Membrane | 3 | 1993 | 3642 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 2 | 2010 | 776 | 0.030 |
Why?
|
| Testis | 2 | 2008 | 783 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 378 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 3 | 2007 | 3760 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1207 | 0.030 |
Why?
|
| Dependovirus | 1 | 1997 | 720 | 0.030 |
Why?
|
| Cerebral Cortex | 2 | 2000 | 5754 | 0.030 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2013 | 163 | 0.030 |
Why?
|
| Ficoll | 1 | 2012 | 39 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 1997 | 802 | 0.020 |
Why?
|
| Age Factors | 3 | 1998 | 18401 | 0.020 |
Why?
|
| Membrane Proteins | 2 | 2021 | 7868 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 1997 | 743 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 1991 | 31 | 0.020 |
Why?
|
| Simplexvirus | 2 | 1987 | 805 | 0.020 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 1992 | 94 | 0.020 |
Why?
|
| Cell Count | 1 | 2016 | 1825 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2000 | 1811 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 2 | 2002 | 879 | 0.020 |
Why?
|
| Virion | 1 | 1994 | 428 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2018 | 1020 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2013 | 739 | 0.020 |
Why?
|
| Occupational Diseases | 1 | 2000 | 1456 | 0.020 |
Why?
|
| Cell-Free System | 1 | 1992 | 339 | 0.020 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1992 | 186 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1993 | 434 | 0.020 |
Why?
|
| Adenine | 1 | 2017 | 995 | 0.020 |
Why?
|
| RNA Precursors | 1 | 1992 | 196 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1621 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2000 | 1900 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2011 | 634 | 0.020 |
Why?
|
| Sarcoma | 1 | 2001 | 1802 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1995 | 857 | 0.020 |
Why?
|
| Models, Animal | 1 | 2017 | 2121 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2018 | 1608 | 0.020 |
Why?
|
| Skin | 1 | 2004 | 4499 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1995 | 781 | 0.020 |
Why?
|
| Phthalazines | 1 | 2013 | 397 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2005 | 1058 | 0.020 |
Why?
|
| B-Cell Activating Factor | 1 | 2010 | 116 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 1 | 1990 | 307 | 0.020 |
Why?
|
| Cytokines | 3 | 2004 | 7446 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 416 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 1993 | 563 | 0.020 |
Why?
|
| Kinetics | 3 | 2002 | 6287 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1992 | 393 | 0.020 |
Why?
|
| Genes, MHC Class II | 2 | 1991 | 433 | 0.020 |
Why?
|
| Thymectomy | 1 | 2010 | 200 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 455 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2011 | 577 | 0.020 |
Why?
|
| Erythrocytes | 3 | 1996 | 2411 | 0.020 |
Why?
|
| Adoptive Transfer | 2 | 2002 | 828 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1996 | 1801 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2012 | 598 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 1697 | 0.020 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2010 | 220 | 0.020 |
Why?
|
| Carnitine | 1 | 2010 | 253 | 0.020 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2009 | 85 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2008 | 220 | 0.020 |
Why?
|
| Trisomy | 1 | 2010 | 260 | 0.020 |
Why?
|
| Luciferases, Renilla | 1 | 2008 | 22 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 487 | 0.020 |
Why?
|
| Body Temperature Regulation | 1 | 2010 | 292 | 0.020 |
Why?
|
| Piperidines | 1 | 2017 | 1667 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 1206 | 0.020 |
Why?
|
| CLOCK Proteins | 1 | 2008 | 87 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2010 | 283 | 0.020 |
Why?
|
| Period Circadian Proteins | 1 | 2008 | 97 | 0.020 |
Why?
|
| Cysteine | 1 | 1993 | 896 | 0.020 |
Why?
|
| ARNTL Transcription Factors | 1 | 2008 | 97 | 0.020 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2008 | 85 | 0.020 |
Why?
|
| Codon | 1 | 1989 | 599 | 0.020 |
Why?
|
| Protein Biosynthesis | 2 | 1988 | 2093 | 0.020 |
Why?
|
| Virus Integration | 1 | 2010 | 307 | 0.020 |
Why?
|
| Yeasts | 1 | 2008 | 278 | 0.020 |
Why?
|
| Bromodeoxyuridine | 2 | 1987 | 310 | 0.020 |
Why?
|
| Calcium Signaling | 2 | 2003 | 736 | 0.020 |
Why?
|
| Starvation | 1 | 2008 | 141 | 0.020 |
Why?
|
| Food Deprivation | 1 | 2007 | 114 | 0.020 |
Why?
|
| Lupus Nephritis | 1 | 1991 | 324 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 425 | 0.020 |
Why?
|
| Morphogenesis | 2 | 2007 | 746 | 0.020 |
Why?
|
| Sperm Count | 1 | 2008 | 227 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2002 | 6611 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2010 | 506 | 0.020 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2006 | 70 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2012 | 1326 | 0.020 |
Why?
|
| Haptens | 2 | 1998 | 163 | 0.020 |
Why?
|
| Teratoma | 1 | 2010 | 405 | 0.020 |
Why?
|
| Poly A | 2 | 1983 | 180 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2017 | 2028 | 0.020 |
Why?
|
| Synapses | 1 | 2016 | 1759 | 0.020 |
Why?
|
| Tumor Necrosis Factors | 1 | 2006 | 109 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2007 | 147 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2010 | 793 | 0.020 |
Why?
|
| Inflammation | 2 | 2003 | 10869 | 0.020 |
Why?
|
| Tyrosine | 2 | 2000 | 1425 | 0.020 |
Why?
|
| Rheumatoid Factor | 1 | 1986 | 185 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 1990 | 649 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 2 | 2006 | 2710 | 0.020 |
Why?
|
| Genetic Code | 1 | 1986 | 139 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2008 | 309 | 0.020 |
Why?
|
| Alternative Splicing | 2 | 2002 | 1103 | 0.020 |
Why?
|
| Solubility | 1 | 2007 | 1078 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2009 | 481 | 0.020 |
Why?
|
| Chromosomes, Artificial, Yeast | 2 | 1995 | 113 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2006 | 216 | 0.020 |
Why?
|
| Virus Replication | 1 | 2013 | 2457 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1987 | 479 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1986 | 313 | 0.020 |
Why?
|
| Chemokine CCL19 | 1 | 2005 | 37 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1986 | 271 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2008 | 371 | 0.020 |
Why?
|
| Electroporation | 1 | 2006 | 238 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2008 | 422 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 2007 | 333 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2010 | 3114 | 0.010 |
Why?
|
| Glucose | 2 | 2007 | 4341 | 0.010 |
Why?
|
| Niacinamide | 1 | 2007 | 417 | 0.010 |
Why?
|
| Haplotypes | 1 | 1991 | 2722 | 0.010 |
Why?
|
| Leishmania major | 1 | 2004 | 60 | 0.010 |
Why?
|
| Cerebellum | 2 | 2004 | 1521 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2017 | 3044 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5716 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1985 | 820 | 0.010 |
Why?
|
| Immunity | 1 | 2010 | 1002 | 0.010 |
Why?
|
| Dinitrophenols | 1 | 2003 | 56 | 0.010 |
Why?
|
| Receptors, Virus | 1 | 1987 | 652 | 0.010 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2003 | 43 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1990 | 716 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 2005 | 286 | 0.010 |
Why?
|
| Calcium | 3 | 2003 | 5792 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 789 | 0.010 |
Why?
|
| Computational Biology | 1 | 2016 | 3567 | 0.010 |
Why?
|
| Chromosomes, Human, 1-3 | 1 | 1983 | 21 | 0.010 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2005 | 308 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2010 | 2221 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2004 | 196 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 2001 | 0.010 |
Why?
|
| Genes, cdc | 1 | 2003 | 113 | 0.010 |
Why?
|
| Phospholipase C gamma | 1 | 2003 | 130 | 0.010 |
Why?
|
| Glutamine | 1 | 2006 | 575 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2006 | 435 | 0.010 |
Why?
|
| Transplantation, Heterologous | 2 | 1988 | 2391 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 287 | 0.010 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2004 | 137 | 0.010 |
Why?
|
| Antigens, CD1d | 1 | 2003 | 226 | 0.010 |
Why?
|
| Thermogenesis | 1 | 2007 | 495 | 0.010 |
Why?
|
| Anaphase | 1 | 2003 | 112 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 88 | 0.010 |
Why?
|
| Cytosol | 1 | 2006 | 885 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 1997 | 326 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2010 | 896 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 2003 | 425 | 0.010 |
Why?
|
| Hair Color | 1 | 2003 | 131 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1980 | 5186 | 0.010 |
Why?
|
| Lymphocyte Cooperation | 1 | 2002 | 112 | 0.010 |
Why?
|
| Tumor Burden | 1 | 2008 | 1903 | 0.010 |
Why?
|
| Piperazines | 1 | 2013 | 2548 | 0.010 |
Why?
|
| Triglycerides | 1 | 2010 | 2444 | 0.010 |
Why?
|
| Genes, Viral | 2 | 1997 | 654 | 0.010 |
Why?
|
| Gene Conversion | 1 | 2002 | 69 | 0.010 |
Why?
|
| Infrared Rays | 1 | 2003 | 249 | 0.010 |
Why?
|
| Killer Cells, Natural | 2 | 2003 | 2209 | 0.010 |
Why?
|
| Histamine | 1 | 2003 | 496 | 0.010 |
Why?
|
| Bleomycin | 1 | 2003 | 492 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1991 | 1559 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2001 | 48 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2007 | 1110 | 0.010 |
Why?
|
| Endopeptidases | 1 | 2005 | 762 | 0.010 |
Why?
|
| Mice, Inbred NZB | 2 | 1991 | 57 | 0.010 |
Why?
|
| Tacrolimus | 2 | 1996 | 751 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2006 | 1504 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2008 | 1757 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 1981 | 100 | 0.010 |
Why?
|
| Superantigens | 1 | 2001 | 124 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 2003 | 619 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2000 | 1352 | 0.010 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2005 | 616 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2008 | 2721 | 0.010 |
Why?
|
| gamma-Globulins | 1 | 2000 | 119 | 0.010 |
Why?
|
| Alum Compounds | 1 | 2000 | 35 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2003 | 577 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1986 | 2342 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2007 | 2602 | 0.010 |
Why?
|
| Asthma | 1 | 2000 | 6268 | 0.010 |
Why?
|
| Cyclin A | 1 | 2000 | 59 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 4903 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1984 | 763 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2003 | 1181 | 0.010 |
Why?
|
| Polyomavirus | 1 | 2001 | 235 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2000 | 1801 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2003 | 676 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2007 | 1368 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 1990 | 110 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2000 | 120 | 0.010 |
Why?
|
| Amino Acids | 1 | 2006 | 1712 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2000 | 185 | 0.010 |
Why?
|
| Salts | 1 | 2000 | 60 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 2002 | 594 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2002 | 391 | 0.010 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2000 | 174 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2000 | 361 | 0.010 |
Why?
|
| Heart | 1 | 1992 | 4429 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2001 | 663 | 0.010 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1999 | 93 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2000 | 1081 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2002 | 861 | 0.010 |
Why?
|
| Luciferases | 1 | 2000 | 713 | 0.010 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2000 | 299 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2000 | 876 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 13650 | 0.010 |
Why?
|
| Oligonucleotides | 2 | 1991 | 561 | 0.010 |
Why?
|
| COS Cells | 1 | 2000 | 1135 | 0.010 |
Why?
|
| Alopecia | 1 | 2003 | 416 | 0.010 |
Why?
|
| Placenta | 1 | 1987 | 1726 | 0.010 |
Why?
|
| Histamine Release | 1 | 1998 | 134 | 0.010 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2000 | 279 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2013 | 42606 | 0.010 |
Why?
|
| Lung | 2 | 2013 | 10076 | 0.010 |
Why?
|
| Glucose-6-Phosphatase | 1 | 1997 | 71 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2000 | 661 | 0.010 |
Why?
|
| Skin Tests | 1 | 2000 | 630 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20169 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 2472 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 697 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1978 | 133 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 4892 | 0.010 |
Why?
|
| Artifacts | 1 | 2006 | 1904 | 0.010 |
Why?
|
| RNA Splicing | 1 | 1982 | 903 | 0.010 |
Why?
|
| Necrosis | 1 | 2001 | 1614 | 0.010 |
Why?
|
| Inhalation Exposure | 1 | 2000 | 432 | 0.010 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 1996 | 42 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1791 | 0.010 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2000 | 527 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 1997 | 205 | 0.010 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2002 | 820 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 573 | 0.010 |
Why?
|
| Transcription Factor AP-2 | 1 | 1996 | 78 | 0.010 |
Why?
|
| Myeloproliferative Disorders | 1 | 2003 | 616 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1646 | 0.010 |
Why?
|
| Anemia | 2 | 1997 | 1514 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 1996 | 38 | 0.010 |
Why?
|
| Aplysia | 1 | 1996 | 40 | 0.010 |
Why?
|
| Leukemia, T-Cell | 1 | 1996 | 102 | 0.010 |
Why?
|
| Protoplasts | 1 | 1995 | 45 | 0.010 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 1996 | 88 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 1996 | 68 | 0.010 |
Why?
|
| Rabbits | 2 | 1995 | 4751 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 1997 | 475 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 1995 | 71 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2007 | 3207 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 1994 | 148 | 0.010 |
Why?
|
| Movement | 1 | 2002 | 1473 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 2457 | 0.010 |
Why?
|
| Calcineurin | 1 | 1996 | 235 | 0.010 |
Why?
|
| Cell Extracts | 1 | 1995 | 134 | 0.010 |
Why?
|
| Blood Cells | 1 | 1996 | 309 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2007 | 3582 | 0.010 |
Why?
|
| Immunoglobulin Light Chains, Surrogate | 1 | 1994 | 5 | 0.010 |
Why?
|
| Bone Density | 1 | 2008 | 3573 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2008 | 6260 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 1751 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2000 | 1132 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1994 | 76 | 0.010 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 1996 | 355 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2002 | 1361 | 0.010 |
Why?
|
| Eye Neoplasms | 1 | 1996 | 305 | 0.010 |
Why?
|
| GATA2 Transcription Factor | 1 | 1994 | 158 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 11063 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1996 | 677 | 0.010 |
Why?
|
| Lens, Crystalline | 1 | 1996 | 387 | 0.010 |
Why?
|
| Eye Proteins | 1 | 1997 | 628 | 0.010 |
Why?
|
| Sheep | 1 | 1996 | 1449 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2005 | 2745 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 1999 | 1182 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2003 | 3227 | 0.010 |
Why?
|
| Child | 2 | 2013 | 80771 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 26396 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1996 | 778 | 0.010 |
Why?
|
| MyoD Protein | 1 | 1993 | 143 | 0.010 |
Why?
|
| Skin Diseases | 1 | 2001 | 1083 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 1996 | 920 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1988 | 12986 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1997 | 1168 | 0.010 |
Why?
|
| Macrophages | 2 | 1998 | 5785 | 0.010 |
Why?
|
| Neutrophils | 1 | 2005 | 3779 | 0.010 |
Why?
|
| Terpenes | 1 | 1992 | 102 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 1996 | 557 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1993 | 1141 | 0.010 |
Why?
|
| Insulin | 1 | 2006 | 6602 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2000 | 1886 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 1995 | 591 | 0.010 |
Why?
|
| Wound Healing | 1 | 2003 | 2800 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 36485 | 0.010 |
Why?
|
| Ligands | 1 | 1998 | 3273 | 0.010 |
Why?
|
| Methotrexate | 1 | 1978 | 1718 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 13646 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2003 | 2160 | 0.010 |
Why?
|
| Carcinogens | 1 | 1992 | 452 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1988 | 361 | 0.000 |
Why?
|
| Muscle Proteins | 1 | 1993 | 1160 | 0.000 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 1987 | 14 | 0.000 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1987 | 30 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2007 | 16036 | 0.000 |
Why?
|
| Reference Values | 1 | 1994 | 4918 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1996 | 10748 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1993 | 1441 | 0.000 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1991 | 1442 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 2000 | 12069 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2001 | 3778 | 0.000 |
Why?
|
| Cell Communication | 1 | 1992 | 1660 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1986 | 828 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1996 | 3464 | 0.000 |
Why?
|
| Pedigree | 1 | 1991 | 4539 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1987 | 2012 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1996 | 4210 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 18063 | 0.000 |
Why?
|
| Adult | 2 | 2000 | 223317 | 0.000 |
Why?
|
| Adolescent | 1 | 2010 | 89046 | 0.000 |
Why?
|
| Stress, Physiological | 1 | 1988 | 1407 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1994 | 10092 | 0.000 |
Why?
|
| Peptides | 1 | 1993 | 4348 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1991 | 4247 | 0.000 |
Why?
|
| Collagen | 1 | 1988 | 2636 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2000 | 41718 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2000 | 54886 | 0.000 |
Why?
|
| Gestational Age | 1 | 1981 | 3618 | 0.000 |
Why?
|